Biologics Market 2021-2030: Global Industry Growth Factors, Trends, Demand Status and Forecast

The global biologics market reached a value of nearly $269,152.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.6% since 2015. The market is expected to decline from $269,152.8 million in 2019 to $239,168.6 million in 2020 at a rate of -11.1%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 14.7% from 2021 and reach $464,604.9 million in 2023.

The Business Research Company offers "Biologics Market Opportunities And Strategies – Global Forecast To 2030" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth and highlights important trends and strategies that players in the market can adopt.

Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.
Some of the key players involved in the Biologics Market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Merck & Co., Inc., Johnson & Johnson

The countries covered in the global Biologics Market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Biologics Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Biologics Market Segmentation:
1)By Type: Monoclonal Antibodies, Therapeutic Proteins
2)By Route Of Administration: Oral, Others (IV or IP)
3)By Drug Classification: Branded Drugs, Generic Drugs
4)By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/biologics-market

A Few Points From The Table Of Content
1. Biologics Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
……
25. Key Mergers And Acquisitions In The Biologics Market
26. Market Background: Pharmaceuticals Market
27. Biologics Market Opportunities And Strategies
8. Biologics Market, Conclusions And Recommendations
29. Appendix

The report covers the trends and market dynamics of the Biologics Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=792

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/

About The Business Research Company:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.